Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

MYCOBACTERIUM - ANVISA Registration 81062710046

Access comprehensive regulatory information for MYCOBACTERIUM in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 81062710046 and manufactured by CEPHEID AB. The registration is held by Cepheid Brasil Importação, Exportação e Comércio de Produtos de Diagnósticos ltda with validity until Mar 14, 2032.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including HAIN LIFESCIENCE GMBH, BECTON DICKINSON AND COMPANY (SPARKS), and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Competitors
5 Recent Registrations
81062710046
2 Related Devices
Registration Details
ANVISA Registration Number: 81062710046
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

Xpert MTB/XDR
Risk Class III

Registration Details

81062710046

25351892588202104

18628083000123

Company Information

CEPHEID AB
Sweden
PT: SUÉCIA

Dates and Status

Mar 14, 2022

14/03/2032

09/18/2025 19:00:01

Xpert MTB/XDR
Risk Class III

Registration Details

81062710046

25351892588202104

18628083000123

Dates and Status

Mar 14, 2022

14/03/2032

09/18/2025 19:00:01